Search Within

Alison Moskowitz

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (47)
  2. Journal Article (35)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (83)
  2. Department of Medicine (83)
  3. Epidemiology and Biostatistics (83)
  4. Hematologic Malignancies, Division of (83)
  5. Lymphoma (83)
  6. Population Sciences Research Program (65)

More Groups

People
  1. Steven Horwitz (65)
  2. Andrew Zelenetz (57)
  3. Anita Kumar (54)
  4. Ariela Noy (54)
  5. Matthew Matasar (54)
  6. David Straus (51)

More People

Years
  1. 2025 (3)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (6)
  5. 2021 (10)
  6. 2020 (10)

More Years

Publications
  1. Blood (33)
  2. Hematological Oncology (10)
  3. Blood Advances (8)
  4. Journal of Clinical Oncology (6)
  5. Blood Cancer Journal (5)
  6. British Journal of Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (41)
  2. Wiley Blackwell (10)
  3. American Society of Clinical Oncology (6)
  4. Nature Publishing Group (6)
  5. Elsevier Inc. (5)
  6. American Association for Cancer Research (4)

More Publishers

Results (83)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of peri-transplant radiation on outcomes in patients with relapsed/refractory classical Hodgkin lymphoma undergoing autologous stem cell transplant
    Meeting Abstract

    Baron, K.; Drill, E.; Ganesan, N.; Merryman, R. W.; Mei, M. G.; Stuver, R.; Desai, S. H.; Falade, A. S.; Iyengar, S.; Micallef, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Quality of life and global response score in cutaneous T-cell lymphoma
    Meeting Abstract

    Khan, N.; Drill, E.; Moskowitz, A.; Shinohara, M. M.; Larocca, C.; Querfeld, C.; Zain, J. M.; Horwitz, S. M.
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy
    Journal Article

    Johnson, W. T.; Ganesan, N.; Epstein-Peterson, Z. D.; Moskowitz, A. J.; Stuver, R. N.; Maccaro, C. R.; Galasso, N.; Chang, T.; Khan, N.; Aypar, U.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Retrospective characterization of nodal marginal zone lymphoma
    Journal Article

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Dogan, A.; Epstein-Peterson, Z. D.; Falchi, L.; Hamlin, P. A.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Characterization of a large cohort of patients with nodal marginal zone lymphoma shows prolonged survival, time-to-treatment, and time-to-transformation
    Meeting Abstract

    Stuver, R.; Drill, E.; Qualls, D.; Okwali, M.; Batlevi, C. L.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Molecular profiling across lymphoma subtypes using MSK-impact next generation sequencing
    Meeting Abstract

    Batlevi, C. L.; Drill, E.; Okwali, M.; Ptashkin, R.; Caron, P. C.; Epstein-Peterson, Z. D.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Identifying primary refractory disease and early relapses in peripheral T-cell lymphoma using baseline characteristics, minimal residual disease, and mutational profiling
    Meeting Abstract

    Stuver, R.; Haynie, H.; Epstein-Peterson, Z. D.; Johnson, W. T.; Khan, N.; Mazloom, A.; Moskowitz, A. J.; Drill, E.; Horwitz, S. M.
    Blood (2022)

    Fulltext@MSK | Save
  • Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: A phase II risk-adapted design
    Journal Article

    Kumar, A.; Casulo, C.; Joffe, E.; Moskowitz, C.; Gerecitano, J.; Moskowitz, A.; Younes, A.; Drullinsky, P.; Drill, E.; Choma, M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save